Welcome to LookChem.com Sign In|Join Free
  • or
Benzoic acid, 4-(3-bromopropoxy)-2-hydroxy-, methyl ester is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

848825-78-5

Post Buying Request

848825-78-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

848825-78-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 848825-78-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,4,8,8,2 and 5 respectively; the second part has 2 digits, 7 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 848825-78:
(8*8)+(7*4)+(6*8)+(5*8)+(4*2)+(3*5)+(2*7)+(1*8)=225
225 % 10 = 5
So 848825-78-5 is a valid CAS Registry Number.

848825-78-5Relevant academic research and scientific papers

Trifunctional norrisolide probes for the study of Golgi vesiculation

Guizzunti, Gianni,Brady, Thomas P.,Malhotra, Vivek,Theodorakis, Emmanuel A.

, p. 320 - 325 (2007)

Inspired by the effect of norrisolide on the Golgi complex, we synthesized norrisolide probes that contain: the perhydroindane core of the parent natural product for Golgi localization, a crosslinking unit (aryl azide or epoxide) for covalent binding to t

Synthesis and evaluation of salicylanilide derivatives as potential epidermal growth factor receptor inhibitors

Hu, Minhua,Ye, Wenfeng,Li, Jiaming,Zhong, Guochen,He, Guangwei,Xu, Qinlong,Zhang, Yanchun

, p. 280 - 289 (2015/03/04)

Two series of novel salicylanilide were synthesized as potential epidermal growth factor receptor (EGFR) inhibitors. The enzyme inhibitory activity against EGFR of all compounds was carried out, and their antiproliferative activities against the A549 and A431 cell lines were also evaluated. Of the compounds studied, majority of them exhibited high antiproliferative activities compared with gefitinib; especially, 12a and 12b exhibited stronger inhibitory activity against EGFR with IC50 values of 10.4 ± 2.25 and 15.4 ± 2.33 nM, respectively, which were comparable to the positive control of gefitinib (IC50 = 12.1 ± 2.21 nM). Compound 12b also showed outstanding inhibitory activity against A431 and A549 cell lines with the IC50 values of 0.42 ± 0.43 μM and 0.57 ± 0.43 μM, which was better than the positive controls. In the molecular modeling study, compound 12b was bound into the active pocket of EGFR with two hydrogen bond and with minimum binding free energy ΔGb = -25.1125 kcal/mol. The result also suggested that compound 12b could bind the EGFR kinase well.

Substituted aryloximes

-

Page/Page column 19, (2010/02/11)

The present invention relates to substituted aryl oximes and methods of using them.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 848825-78-5